Influence of Spinal Stimulation Frequency on Spasticity, Motor Control, and Pain After Spinal Cord Injury

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-19

Study Completion Date

2026-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to identify the effect of different types of noninvasive spinal stimulation on spasticity (involuntary muscle activity), muscle strength, and pain in people with spinal cord injury. The spinal stimulation consists of electrical stimulation applied through one electrode over the skin of the lower back and two electrodes over the stomach. Testing will include participating in measurements before the intervention, during intervention, and immediately after the intervention. This study requires participants to come into Shepherd Center 4 consecutive days a week for 2-3 hours per day across 2-3 weeks.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Influence of Wearable Intensive Nerve Stimulation on Spasticity and Function in Persons With Spinal Cord Injury

NCT04130295

Spinal Cord Injuries Spasticity, Muscle

COMPLETED NA

Spinal Cord Stimulation to Augment Activity Based Therapy

NCT03240601

Transcutaneous Spinal Stimulation Walking Spasticity +2 more

COMPLETED NA

Influence of Transcutaneous Spinal Stimulation Intensity on Spasticity After SCI

NCT04243044

Spinal Cord Injuries

COMPLETED NA

"Epidural Spinal Cord Stimulation: Addressing Spasticity and Motor Function"

NCT05422716

Spasticity

NOT_YET_RECRUITING NA

Neuromodulation to Reduce Muscle Stiffness Following Spinal Cord Injury

NCT06274021

Spinal Cord Injuries Spinal Cord Injury Spinal Cord Injury Cervical +1 more

RECRUITING EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Transcutaneous spinal stimulation (TSS) is a noninvasive electrical stimulation that is applied over the skin of the low back and stomach. In prior research studies, TSS has reduced spasticity without the negative side effects of drug therapies. Although research in TSS is growing, the best dosage of TSS remains unknown. The investigators want to further advance the effects of TSS by comparing three different frequencies. Frequency is the number of electrical pulses that are delivered over a period of time. Frequency can affect the activation of nerves and therefore affect the outcome of TSS. Participation in this study includes testing of the participants' spasticity, strength, and pain before and after 30 minutes of TSS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

30 Hz Frequency

Intervention will be applied with a 30 Hz frequency.

Group Type EXPERIMENTAL

Transcutaneous Spinal Stimulation

Intervention Type OTHER

Transcutaneous spinal stimulation will be delivered for 30 minutes using biphasic pulses. A single cathode electrode will be placed over the skin of the back spine at the T11/T12 spinous interspace. Two reference electrodes will be placed over the stomach. Stimulation intensity will be set to 0.8x reflex threshold, as determined by posterior root muscle reflex testing before the intervention. Treatments will be a minimum of 72 hours apart.

50 Hz Frequency

Intervention will be applied with a 50 Hz frequency.

Group Type EXPERIMENTAL

Transcutaneous Spinal Stimulation

Intervention Type OTHER

Transcutaneous spinal stimulation will be delivered for 30 minutes using biphasic pulses. A single cathode electrode will be placed over the skin of the back spine at the T11/T12 spinous interspace. Two reference electrodes will be placed over the stomach. Stimulation intensity will be set to 0.8x reflex threshold, as determined by posterior root muscle reflex testing before the intervention. Treatments will be a minimum of 72 hours apart.

80 Hz Frequency

Intervention will be applied with an 80 Hz frequency.

Group Type EXPERIMENTAL

Transcutaneous Spinal Stimulation

Intervention Type OTHER

Transcutaneous spinal stimulation will be delivered for 30 minutes using biphasic pulses. A single cathode electrode will be placed over the skin of the back spine at the T11/T12 spinous interspace. Two reference electrodes will be placed over the stomach. Stimulation intensity will be set to 0.8x reflex threshold, as determined by posterior root muscle reflex testing before the intervention. Treatments will be a minimum of 72 hours apart.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcutaneous Spinal Stimulation

Transcutaneous spinal stimulation will be delivered for 30 minutes using biphasic pulses. A single cathode electrode will be placed over the skin of the back spine at the T11/T12 spinous interspace. Two reference electrodes will be placed over the stomach. Stimulation intensity will be set to 0.8x reflex threshold, as determined by posterior root muscle reflex testing before the intervention. Treatments will be a minimum of 72 hours apart.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must agree to allow use of health information.
* Participants should be 16 years old or older.
* Participants must have had a spinal cord injury (SCI) of any severity (AIS A, B, C, or D) that happened at least 3 months ago.
* Objectively measurable spasticity in your legs.
* Participants must inform the investigators if there is a change in medications during the study.
* Participants must be able to follow instructions.
* Participants must be able to communicate if pain or discomfort is experienced.

Exclusion Criteria

* People with spinal issues that are getting worse, such as degenerative or progressive vascular disorders.
* People neurological problems other than SCI.
* People with an injury level is below T12.
* People with un-treated or uncontrolled heart problems that the lead investigator believes could be affected by stimulation or affected by an increase in blood pressure.
* People with bone or joint problems that would make it hard to follow the study plan.
* Women who are pregnant or actively trying to become pregnant.
* People with implanted stimulators (like a baclofen pump, spinal stimulator, heart defibrillator, or diaphragmatic pacemaker)
* People with infection.
* People with skin that is broken or wounds in the area of the body where stimulation is applied.
* People who have or had certain types of cancer in the area of the body where stimulation will be applied.
* People who have had botulinum toxin or numbing shots in the test leg or spine in the last 6 months
* People who have had permanent spasticity treatment in the test leg or spine (like a certain type of surgery).
* Other health issues that the lead investigator things could make it unsafe for you to join the study.

Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No